Why breast cancer signatures are no better than random signatures explained

Random signature superiority (RSS) occurs when random gene signatures outperform published and/or known signatures. Unlike reproducibility and generalizability issues, RSS is relatively underexplored. Yet, understanding it is imperative for better analytical outcome. In breast cancer, RSS correlates...

Full description

Saved in:
Bibliographic Details
Main Authors: Goh, Wilson Wen Bin, Wong, Limsoon
Other Authors: School of Biological Sciences
Format: Article
Language:English
Published: 2020
Subjects:
Online Access:https://hdl.handle.net/10356/137544
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-137544
record_format dspace
spelling sg-ntu-dr.10356-1375442023-02-28T17:06:34Z Why breast cancer signatures are no better than random signatures explained Goh, Wilson Wen Bin Wong, Limsoon School of Biological Sciences Science::Biological sciences Bioinformatics Statistics Random signature superiority (RSS) occurs when random gene signatures outperform published and/or known signatures. Unlike reproducibility and generalizability issues, RSS is relatively underexplored. Yet, understanding it is imperative for better analytical outcome. In breast cancer, RSS correlates strongly with enrichment for proliferation genes and signature size. Removal of proliferation genes from random signatures reduces the predictive power of random signatures. Almost all genes are correlated to a certain extent with the proliferation signature, making complete elimination of its confounding effects impossible. RSS goes beyond breast cancer, because it also exists in other diseases; it is especially strong in other cancers in a platform-independent manner, and less severe, but present nonetheless, in nonproliferative diseases. Accepted version 2020-04-01T05:01:04Z 2020-04-01T05:01:04Z 2018 Journal Article Goh, W. W. B., & Wong, L. (2018). Why breast cancer signatures are no better than random signatures explained. Drug Discovery Today, 23(11), 1818-1823. doi:10.1016/j.drudis.2018.05.036 1359-6446 https://hdl.handle.net/10356/137544 10.1016/j.drudis.2018.05.036 29864526 2-s2.0-85048445981 11 23 1818 1823 en Drug Discovery Today © 2018 Elsevier Ltd. All rights reserved. This paper was published in Drug Discovery Today and is made available with permission of Elsevier Ltd. application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic Science::Biological sciences
Bioinformatics
Statistics
spellingShingle Science::Biological sciences
Bioinformatics
Statistics
Goh, Wilson Wen Bin
Wong, Limsoon
Why breast cancer signatures are no better than random signatures explained
description Random signature superiority (RSS) occurs when random gene signatures outperform published and/or known signatures. Unlike reproducibility and generalizability issues, RSS is relatively underexplored. Yet, understanding it is imperative for better analytical outcome. In breast cancer, RSS correlates strongly with enrichment for proliferation genes and signature size. Removal of proliferation genes from random signatures reduces the predictive power of random signatures. Almost all genes are correlated to a certain extent with the proliferation signature, making complete elimination of its confounding effects impossible. RSS goes beyond breast cancer, because it also exists in other diseases; it is especially strong in other cancers in a platform-independent manner, and less severe, but present nonetheless, in nonproliferative diseases.
author2 School of Biological Sciences
author_facet School of Biological Sciences
Goh, Wilson Wen Bin
Wong, Limsoon
format Article
author Goh, Wilson Wen Bin
Wong, Limsoon
author_sort Goh, Wilson Wen Bin
title Why breast cancer signatures are no better than random signatures explained
title_short Why breast cancer signatures are no better than random signatures explained
title_full Why breast cancer signatures are no better than random signatures explained
title_fullStr Why breast cancer signatures are no better than random signatures explained
title_full_unstemmed Why breast cancer signatures are no better than random signatures explained
title_sort why breast cancer signatures are no better than random signatures explained
publishDate 2020
url https://hdl.handle.net/10356/137544
_version_ 1759857445098749952